• Home
  • Updates
  • More Details
  • Resources

Problems with immunotherapy for EGFR NSCLC

  • Den
    Den
  • October 13th, 2024
  • No Comments
2024 Efficacy and safety of immune checkpoint inhibitors for individuals with advanced EGFR-mutated non-small-cell lung cancer wDownload
    Leave a Reply Cancel reply

    You must be logged in to post a comment.

    Continue with Google
    Previous Post

    Immunotherapy for EGFR+ NSCLC

    Next Post

    Targeted Osimertinib consolidation for Den.